No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomised, double-blind, placebo-controlled trial.
Carr A, Workman C, Carey D, Rogers G, Martin A, Baker D, Wand H, Law M, Samaras K, Emery S, Cooper DA; Rosey investigators.
Lancet. 2004 Feb 7;363(9407):429-38.PMID: 14962523 [PubMed - indexed for MEDLINE]Related articles